Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer-related issues for women

R M Rospond1

  • 1Creighton University, School of Pharmacy and Allied Health Professions, Omaba, Nebr, USA.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|November 1, 1996
PubMed
Summary

Lifestyle choices like tobacco use and diet significantly impact cancer risk, with many deaths being preventable. Early screening and emerging vaccines offer hope for reducing cancer mortality, highlighting the role of healthcare professionals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new transmucosal fentanyl for breakthrough cancer pain.

Cancer practice·2000
Same author

Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study.

Journal of pain and symptom management·1996
Same author

Hepatic artery chemoembolization therapy for hepatic tumors.

AORN journal·1995
Same author

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1994
Same author

Obtaining reimbursement for oncology pharmacy services provided to ambulatory patients.

American journal of hospital pharmacy·1993
Same author

Dimethyl sulfoxide for treating anthracycline extravasation.

Clinical pharmacy·1993

Area of Science:

  • Oncology
  • Preventive Medicine
  • Public Health

Background:

  • Tobacco and diet are major contributors to cancer mortality, accounting for nearly two-thirds of all cancer-related deaths.
  • A significant portion of cancer deaths, up to 35%, are potentially avoidable through timely and appropriate screening measures.
  • Advancements in medical research, particularly in vaccine development, are showing promise for both the treatment and prevention of various cancers.

Purpose of the Study:

  • To highlight the significant impact of modifiable lifestyle factors on cancer-related mortality.
  • To emphasize the potential of screening and emerging vaccine therapies in cancer prevention and treatment.
  • To outline the crucial role pharmacists can assume in enhancing women's health outcomes within oncology.

Main Methods:

  • Review of epidemiological data on cancer risk factors.
  • Analysis of current screening guidelines and their impact on mortality rates.
  • Exploration of recent research trends in cancer vaccines and therapeutic strategies.
  • Assessment of the pharmacist's scope of practice in patient advocacy and supportive care.

Main Results:

  • Tobacco use and dietary habits are identified as the most critical and correctable risk factors for cancer.
  • Effective implementation of screening measures could prevent a substantial percentage of cancer-related deaths.
  • Research into cancer vaccines is rapidly advancing, offering new avenues for intervention.
  • Pharmacists are positioned to significantly contribute to women's health through advocacy, referrals, and supportive care recommendations.

Conclusions:

  • Addressing modifiable risk factors like tobacco and diet is paramount for reducing cancer burden.
  • Enhanced screening protocols and novel vaccine therapies represent key strategies for cancer prevention and control.
  • Pharmacists are integral members of the healthcare team, capable of improving patient outcomes, particularly in women's health and oncology support.

Related Experiment Videos